PPIG and acute kidney injury: Recent studies have revealed that variations in the CYP-like AA pathway may increase the likelihood of developing AKI, and targeted drug interventions aimed at this pathway may provide novel preventive measures for AKI [122], but clinical research on CYP in AKI is currently very limited, and the side effects and individual differences associated with CYP cannot be ignored.